Product
LNF1901
1 clinical trial
1 indication
Indication
Advanced Malignant TumorsClinical trial
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Initial Efficacy of LNF1901 in Advanced Malignant TumorsStatus: Not yet recruiting, Estimated PCD: 2025-02-01